ReviewAnimals : an open access journal from MDPI2024
The Global Rise of ESBL-Producing
Review in Animals : an open access journal from MDPI, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Prevalence and Genomic Characterization of ESBL-ProducingAntibiotics (Basel, Switzerland) · 2026Article
- Occurrence of multidrug-resistant extended-spectrum β-lactamase (ESBL)-producingMicrobiology spectrum · 2026Article
- Influence of housing system on antimicrobial resistance and population structure of extended-spectrum beta-lactamase-producing Escherichia coli in South Korean layer farms.Poultry science · 2026Article
- Interconnected Reservoirs: Virulence & Biofilm Traits of ESBL-Microorganisms · 2026Article
- ESBL and carbapenemase-producing enteric pathogens in animal-origin foods: a one health perspective.Folia microbiologica · 2026Review
- Systematic Review and Meta-Analysis of Extended-Spectrum Beta-Lactamase-Producing (ESBL)Antibiotics (Basel, Switzerland) · 2026Review
- Antimicrobial resistance of Escherichia coli in Hungarian wild rats and characterization of a CTX-M-1 type ESBL plasmid.Scientific reports · 2026Article
- High prevalence of CTX-M-1 and CTX-M-15 extended-spectrum β-lactamase-producingVeterinary world · 2026Article
- Tracking ESBL-ProducingVeterinary sciences · 2026Article
- Fecal carriage, transferable β-lactam resistance, and efflux pump contribution in third-generation cephalosporin-resistantVeterinary world · 2026Article
- Captive ungulates as sentinels of antimicrobial resistance: genomic and phenotypic characterization of extended-spectrum β-lactamase-producingFrontiers in veterinary science · 2026Article
- Prevalence of ESBL-ProducingPathogens (Basel, Switzerland) · 2025Article
- Article
- Co-Occurrence and Molecular Characterization of ESBL-Producing and Colistin-ResistantFoods (Basel, Switzerland) · 2025Article
- Can Improved Biosecurity Measures Reduce the Presence of the Most Common ESBL-ProducingLife (Basel, Switzerland) · 2025Article
- Occurrence and Molecular Characterization of Extended-Spectrum Beta-Lactamase (ESBL)-ProducingAntibiotics (Basel, Switzerland) · 2025Article
- Unravelling mutation patterns in Extended-Spectrum β-Lactamases for precision drug design against AMR in Enterobacteriaceae.Molecular genetics and genomics : MGG · 2025Article
- Unexplained High Prevalence of ESBL-Antibiotics (Basel, Switzerland) · 2025Article
- Trends and patterns of antimicrobial resistance among common pathogens isolated from adult bloodstream and urinary tract infections in public health facilities in Malawi, 2020-2024.BMC infectious diseases · 2025Article
- ESBL-producing Enterobacterales in food and clinical samples: antimicrobial resistance organisms and genes in Chiang Mai, Thailand.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
β-lactam antibiotics are a key element in the treatment of bacterial infections. However, the excessive use of these antibiotics has contributed to the emergence of β-lactam-resistant enterobacteria, including
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.